food and drug administration

MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…

Shelby Knowles / Bloomberg / Getty Images Eli Lilly shares have added over a third of their value…

FDA requests, and Vanda agrees to, a brief extension (to December 5, 2025) for the expedited re-review of…

While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis,…

More than half a million bottles of a popular blood pressure medication have been recalled because they contain…

The U.S. Food and Drug Administration announced Wednesday that it will relax certain rules for approving low-cost versions…

More than half a million bottles of a popular blood pressure medication have been recalled because they contain…

The Food and Drug Administration is reviewing the safety of the abortion pill mifepristone, Health and Human Services…

A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy…

This article first appeared on GuruFocus. Apple (AAPL, Financials) is adding a new health feature to its Watch…

US regulators issued a flurry of letters calling out pharmaceutical companies for allegedly misleading ads, part of a…

FDA leaders under President Trump are moving to abandon a decades-old policy of asking outside experts to review…

MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease